
Administration may cut funds to hospitals offering gender care to kids
July 1 (UPI) -- The Trump administration may cut off federal funding to hospitals that provide gender-related treatments to children and teens.
Nine major children's hospitals recently received letters from federal officials seeking information about procedures such as hormone therapy, puberty blockers and sex-reassignment surgeries, The Wall Street Journal reported.
Dr. Mehmet Oz, who now leads the Centers for Medicare and Medicaid Services, said the goal is to protect children from "life-altering and experimental procedures."
"CMS has warned hospitals and state Medicaid programs about these dangers - and is taking regulatory enforcement actions," Oz said.
Officials at CMS say they are looking into whether they can block federal Medicaid or insurance funding to hospitals that offer such care.
They're also reviewing whether hospitals could be removed from Medicaid entirely if they continue to treat minors for gender-related issues, The Wall Street Journal said.
Most children's hospitals depend heavily on Medicaid.
One of the hospitals that received a letter, Children's Hospital Los Angeles, has already announced it will shut down its gender-related care program. The hospital said more than 65% of its funding comes from federal sources.
"These threats are no longer theoretical. The federal government has already cut off hundreds of millions of dollars from U.S. academic and research institutions," hospital leaders said in a June 12 letter to the staff.
Boston Children's Hospital said it has a legal duty under Massachusetts law to provide access to gender-affirming care and is still reviewing the CMS letter.
The letters were sent as part of a broader effort by the administration to restrict gender-affirming care for minors.
In April, U.S. Attorney General Pam Bondi said the Justice Department would investigate doctors and hospitals that perform gender-related surgeries or mislead families about treatment.
The U.S. Supreme Court ruled last week that states can limit access to these treatments for minors, and more Americans are expressing concern about transgender-related policies in schools and sports.
According to nonprofit health research group KFF, 27 states now have laws or policies that restrict gender-related care for children and teens.
Some hospitals that received the CMS letter are scaling back services. UPMC Children's Hospital in Pittsburgh said it would stop offering puberty blockers, citing the risk of legal action, The Wall Street Journal said.
"As we continue to monitor executive-branch memos, directives and other guidance from the federal government, these actions have made it abundantly clear that our clinicians can no longer provide certain types of gender-affirming care without risk of criminal prosecution," a hospital spokesperson said.
The nine hospitals that received letters include: Children's Hospital of Philadelphia, Seattle Children's Hospital, Children's Hospital Los Angeles, Boston Children's Hospital, Children's National Hospital, UCSF Benioff Children's Hospital Oakland, Children's Hospital Colorado, UPMC Children's Hospital of Pittsburgh and Cincinnati Children's Hospital Medical Center, The Wall Street Journal reported.
Children's Hospital Colorado and Cincinnati Children's both said they don't perform surgeries for minors.
Ellen Kahn, senior vice president of the Human Rights Campaign said transgender surgeries for youth are rare and that parents, doctors and patients should make those decisions.
"Studies consistently show that affirming care reduces depression, anxiety and suicide risk among transgender youth," she said.
"The Centers for Medicare and Medicaid Services should protect healthcare, not politicize it," she added.
Supporters of gender-related treatments say these services are often life-saving for young people with gender dysphoria. But others argue there is not enough evidence yet about any long-term outcomes.
More information
The HHS Office of Population Affairs has more on gender-affirming care for young people.
Copyright © 2025 HealthDay. All rights reserved.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


American Press
25 minutes ago
- American Press
Rollins extends sugary drinks ban to six more states — including Louisiana
U.S. Secretary of Agriculture Brooke Rollins approved six waivers to exclude sodas and energy drinks from federal nutrition programs on Monday. Rollins signed waivers exempting soda and energy drinks from being included in the Supplemental Nutrition Assistance Programs in Colorado, Florida, Louisiana, Oklahoma, Texas and West Virginia. The six states join Arkansas, Idaho, Iowa, Indiana, Utah and Nebraska in restricting sodas and energy drinks from SNAP. 'Since my confirmation, our department has encouraged states to think differently and creatively about how to solve the many health issues facing Americans,' Rollins said. 'One way is by not allowing taxpayer-funded benefits to be used to purchase unhealthy items like soda, candy and other junk food.' Critics of the new push to ban soda and energy drinks under SNAP say it unfairly targets lower-income families, limits consumer choice and won't result in better health outcomes. Colorado Gov. Jared Polis is the first Democrat governor to request a waiver of sugary drinks from the states SNAP program. 'This is not red or blue, Republican or Democrat. We are discussing and working with every state. So (I am) really excited to continue to work with Gov. Polis,' Rollins said. Secretary of Health and Human Services Robert F. Kennedy Jr., Food and Drug Administration Commissioner Marty Makary, Iowa Gov. Kim Reynolds and West Virginia Gov. Patrick Morrisey joined Rollins for the announcement. Morrisey praised his state's inclusion as part of the SNAP waiver program. He said the lack of access to healthy foods in West Virginia contributes to the prevalence of chronic disease in residents. 'I'm happy now that West Virginia taxpayers are not going to be subsidizing soda and these sugary drinks, things that have no nutritional value and are directly linked to obesity, diabetes, and a lot of other terrible health care outcomes,' Morrisey said. HHS Secretary Kennedy agreed with Morrisey. He said the inclusion of soda and energy drinks in SNAP increases the cost to medicaid and medicare programs due to increased chronic disease. 'U.S. taxpayers should not be paying to feed kids foods – the poorest kids in our country – with foods that are the gift of diabetes. And my agency ends up through Medicaid and Medicare paying for those injuries,' Kennedy said. Kennedy also gave an update on the dietary guidelines for Americans that he is working alongside Rollins to complete. He said the guidelines will be complete in late September, 'three months ahead of schedule.' 'They will drive changes in the school lunch program, in prison lunches and military food, and they will begin to change America almost immediately,' Kennedy said. Not everyone agrees. 'Make no mistake, this waiver won't make an ounce of difference on health,' the trade organization American Beverage said when a waiver was being discussed in Ohio. 'Obesity has skyrocketed in the last two decades while beverage calories per serving have dropped by 42% – thanks to our industry's efforts to empower Americans with more choice and information. In fact, 60% of beverages Americans buy today have zero sugar due to our innovation.' The U.S. government spent $112.8 billion on SNAP in 2023, covering 100% of the cost of food benefits and 50% of states' administrative costs.


American Press
25 minutes ago
- American Press
25 states file legal brief defending Trump ban on youth sex change procedures
On Monday, Louisiana Attorney General Liz Murrill joined 24 other Republican attorneys general in backing President Donald Trump's executive order aimed at halting federal funding for sex change procedures on minors, marking the state's latest push in a broader legal fight over transgender care. Three days earlier, Massachusetts filed a brief joined by 19 states challenging the same executive order. The states argue the order is unconstitutional, discriminatory, and violates the Spending Clause by tying federal health funds to ideological conditions. The Massachusetts-led brief contends that the order jeopardizes care for transgender youth, strips states of medical decision-making authority, and undermines long-standing Medicaid protections. The suit seeks a declaratory judgment and permanent injunction against implementation. The attorneys general defending the Trump order, led by Alabama's Steve Marshall, filed amicus briefs in the 4th and 9th U.S. Circuit Courts of Appeals, supporting Trump's order and urging the courts to overturn preliminary injunctions issued earlier this year in lawsuits out of Washington and Maryland. The Alabama-led briefs argue that continuing to fund such procedures violates both medical ethics and constitutional principles. 'Even though President Trump is in office, common sense and constitutional principles are under constant assault by radical leftist groups like the ACLU,' said Alabama Attorney General Steve Marshall, who is leading the coalition. Marshall accused the ACLU of pushing courts to 'force taxpayers to fund sex-change procedures on children.' Murrill, who has been an outspoken critic of so-called 'gender-affirming' care for minors, did not release a separate public statement, but her participation in the brief underscores Louisiana's alignment with a growing number of Republican-led states that seek to limit access to such treatments. In recent years, Louisiana's Legislature has passed bans on puberty blockers and hormone treatments for minors. According to the coalition's legal filings, the brief draws on findings from Alabama's discovery in a now-dismissed challenge to its own ban on 'gender-affirming' care, where Marshall's office claimed to uncover a coordinated effort to remove age restrictions from national medical guidelines — a move he described as politically motivated rather than science-based. The Alabama-led team argues that federal funding for 'gender-affirming' care is based on 'discredited standards' and that such medical interventions for minors have irreversible consequences. 'The evidence says otherwise,' Marshall said. 'These harmful interventions have lasting consequences for vulnerable children.' The Alabama-led brief was filed in both the 9th Circuit and 4th Circuit federal courts of appeal. Louisiana was joined by attorneys general from Alaska, Arkansas, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Mississippi, Missouri, Nebraska, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, and Wyoming in addition to Louisiana. The filings are part of a broader conservative legal strategy seeking to bolster state laws banning so-called 'gender-affirming' care while reinforcing Trump-era federal policy that frames such care as medically unnecessary and ideologically driven.


UPI
27 minutes ago
- UPI
Former X CEO Linda Yaccarino takes eMed top job
Linda Yaccarino will join eMed as its CEO after leaving her role as CEO of X. File Photo by James Atoa/UPI | License Photo Aug. 5 (UPI) -- The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino has been appointed its new CEO. "Yaccarino's hiring is a game changing moment in eMed's mission to make safe, effective, and sustainable chronic care accessible directly through an all-in-one, digital-first experience," eMed said in a press release. "Her unparalleled experience in leading paradigm shifting transformations will bring a new dimension to the company." Yaccarino had stepped down from her post at X in July after a two-year stint without an explanation, but her resignation came a day after the X chatbot Grok had gone on an anti-Semitic tirade. EMed is currently at work on a population health management platform for the GLP-1 weight loss and diabetes drugs. Goldman Sachs researchers have estimated that about 15 million adults in the United States alone may be treated with anti-obesity medications, or AOMs by 2030, and that the industry could reach $100 billion in annual revenue by that year. "The healthcare industry has been disrupted by technology, but not yet completely transformed by it," Yaccarino said in the release. "There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before."